Orient Securities released a research report stating that the impact of this round of procurement on the pharmaceutical and biological industry: 1) Abnormally low prices are restrained, which helps ease the price pressure on conventional consumables; 2) Mature varieties such as hemostasis clips mainly have a stable share, and snares, injections, and high-value pancreatic interventional products will be the focus of enterprises seeking growth. It is recommended to focus on two types of enterprises: 1) companies with leading coverage of major high-frequency varieties, capable of covering hospitals across the country, and stable supply; 2) enterprises with reserves of pancreatic interventional products and overseas private brand business.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.